<!DOCTYPE html>
<html lang="en">
<head>
  <title>Bootstrap Example</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="stylesheet" href="../bootstrap/bootstrap.min.css">
  <script src="../bootstrap/jquery.min.js"></script>
  <script src="../bootstrap/bootstrap.min.js"></script>
  <!-- <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css">
  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>
  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script> -->
  <link rel="stylesheet" type="text/css" href="../css/NavBarBoot.css">
  <script
  src="https://code.jquery.com/jquery-3.2.1.min.js"
  integrity="sha256-hwg4gsxgFZhOsEEamdOYGBf13FyQuiTwlAQgxVSNgt4="
  crossorigin="anonymous"></script>
  <script src="../js/notebookJQ.js"></script>
  <script src="../js/general.js"></script>
</head>
<body>


	<nav class="navbar navbar-inverse menu">
	 	<div class="menu-container">
			<!-- <div class="navbar-header"> -->
				<div class="menu-logo-container">
					<a href="http://2018.igem.org/Team:Purdue">
						<img src="../photos/logo_cropped.png">
					</a>
				</div>
	    	<!-- </div> -->
	    	<div class="container menu-items">
		    	<ul class="nav navbar-nav">
		      		<li class="dropdown">
		      			<a href="#">Team
		      				<span class="caret"></span></a>
		      			<ul class="dropdown-menu">
		      				<li><a href="#">Team Members</a></li>
		      				<li><a href="#">Collaborations</a></li>
						</ul>
		      		</li>
					<li class="dropdown">
						<a href="#">Project
							<span class="caret"></span></a>
						<ul class="dropdown-menu">
							<li><a href="http://2018.igem.org/Team:Purdue/Description">Description</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Design">Design</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Experiments">Experiments</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Notebook">Notebook</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/InterLab">InterLab</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Model">Model</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Demonstrate">Demonstrate</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Improve">Improve</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Attributions">Attributions</a></li>
						</ul>
					</li>
					<li class="dropdown">
						<a href="#">Parts
							<span class="caret"></span></a>
						<ul class="dropdown-menu">
							<li><a href="http://2018.igem.org/Team:Purdue/Parts">Parts Overview</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Basic_Part">Basic Parts</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Composite_Part">Composite Parts</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Part_Collection">Part Collection</a></li>
						</ul>
					</li>
					<li><a href="http://2018.igem.org/Team:Purdue/Safety">Safety</a></li>
					<li class="dropdown">
						<a href="#">Human Practices
							<span class="caret"></span></a>
						<ul class="dropdown-menu">
							<li><a href="http://2018.igem.org/Team:Purdue/Human_Practices">Human Practices</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Public_Engagement">Education &amp; Engagement</a></li>
						</ul>
					</li>
					<li class="dropdown">
						<a href="#">Awards
							<span class="caret"></span></a>
						<ul class="dropdown-menu">
							<li><a href="http://2018.igem.org/Team:Purdue/Applied_Design">Applied Design</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Entrepreneurship">Entrepreneurship</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Hardware">Hardware</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Measurement">Measurement</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Model">Model</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Plant">Plant</a></li>
							<li><a href="http://2018.igem.org/Team:Purdue/Software">Software</a></li>
						</ul>
					</li>
					<li><a href="http://igem.org/2018_Judging_Form?team=Purdue">Judging Form</a></li>
		    	</ul>
	    	</div>
	    	<div class="menu-hamburger">
	    		<a href='#'>
	    		<div></div>
	    		<div></div>
	    		<div></div>
	    		</a>
	    	</div>
	 	</div>
	</nav>

	<!-- <div class="basic-page"> -->
	<div class="nav-menu-side">
		<ul>
      		<li class="dropdown-side">
      			<a href="#">Team
      				<span class="caret"></span></a></li>
  			<ul class="dropdown-menu-side">
  				<li><a href="#">Team Members</a></li>
  				<li><a href="#">Collaborations</a></li>
			</ul>
			<li class="dropdown-side">
				<a href="#">Project
					<span class="caret"></span></a></li>
			<ul class="dropdown-menu-side">
				<li><a href="http://2018.igem.org/Team:Purdue/Description">Description</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Design">Design</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Experiments">Experiments</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Notebook">Notebook</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/InterLab">InterLab</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Model">Model</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Demonstrate">Demonstrate</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Improve">Improve</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Attributions">Attributions</a></li>
			</ul>
			<li class="dropdown-side">
				<a href="#">Parts
					<span class="caret"></span></a></li>
			<ul class="dropdown-menu-side">
				<li><a href="http://2018.igem.org/Team:Purdue/Parts">Parts Overview</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Basic_Part">Basic Parts</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Composite_Part">Composite Parts</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Part_Collection">Part Collection</a></li>
			</ul>
			<li><a href="http://2018.igem.org/Team:Purdue/Safety">Safety</a></li>
			<li class="dropdown-side">
				<a href="#">Human Practices
					<span class="caret"></span></a></li>
			<ul class="dropdown-menu-side">
				<li><a href="http://2018.igem.org/Team:Purdue/Human_Practices">Human Practices</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Public_Engagement">Education &amp; Engagement</a></li>
			</ul>
			<li class="dropdown-side">
				<a href="#">Awards
					<span class="caret"></span></a></li>
			<ul class="dropdown-menu-side">
				<li><a href="http://2018.igem.org/Team:Purdue/Applied_Design">Applied Design</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Entrepreneurship">Entrepreneurship</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Hardware">Hardware</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Measurement">Measurement</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Model">Model</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Plant">Plant</a></li>
				<li><a href="http://2018.igem.org/Team:Purdue/Software">Software</a></li>
			</ul>
			<li><a href="http://igem.org/2018_Judging_Form?team=Purdue">Judging Form</a></li>
    	</ul>
	</div>
</body>
</html>

<html>
<link rel="stylesheet" type="text/css" href="../css/StandardStyling.css" />
<script src="../js/referencesJQ.js"></script>
<body>
	<div class = "basic-page">
		<div class = "basic-header">
			<img src="../photos/bread3.jpg"/>
			<p>Project Description</p>
		</div>
		<div class="container basic-page-body">
			<h1>Abstract</h1>
				<p>Systemic candidiasis, caused by the fungal pathogen Candida albicans, is the fourth leading cause of hospital-acquired infections, with a mortality rate of up to 49%. Vulvovaginal candidiasis, the common yeast infection, occurs in 75% of women during their lifetime and can be passed to a woman’s child during pregnancy. Current methods for diagnosis include cell cultures, which can be time-consuming, and pH tests, which are less accurate. Timely diagnosis of candidiasis, especially in rural or underdeveloped regions, is challenging because it requires specialized equipment and expertise. Continuous misdiagnosis leads to inappropriately prescribed antimicrobials and promotes an increase in multidrug-resistant pathogens, decreasing the viability of current treatments. Purdue iGEM is developing a paper-based diagnostic test for C. albicans that is rapid, cost-effective, and user-friendly. The test detects the biomarkers farnesol and tyrosol by binding them to the proteins pqsR and tyrosinase respectively. Upon binding, horseradish peroxidase activates and produces an amplified colorimetric signal by oxidizing the substrate tetramethylbenzidine (TMB). Implementing our diagnostic test will provide users with a simple, colorimetric output, which can be interpreted to take the appropriate action. Using such a test will control the abuse of antifungals and thus limit the propagation of antimicrobial resistance.
				</p>
			<h1> Why our project matters.</h1>
				<p> Vulvovaginal and invasive candidiasis are the most impactful and prevalent fungal infections in humans. Although intercourse, pregnancy, and a weak immune system increase one’s predisposition to contacting vulvovaginal yeast infections, there is no guaranteed way to prevent its contraction. 
				Vulvovaginal candidiasis displays symptoms including an uncomfortable burning sensation during urination, genital itching, and rashes <a class="ref-link" href="#">[6]</a>. Failure to diagnose vulvovaginal yeast infections accurately can lead to other chronic and severe infections <a class="ref-link" href="#">[15]</a>. When mistreated, 
				the inappropriate prescription of antibiotics not only contributes to the growing danger of antibiotic-resistant strains of bacteria but can kill native bacteria and worsen the infection<a class="ref-link" href="#">[2]</a>. 
				In an invasive yeast infection, C. albicans can enter other parts of the body such as the heart, brain, and bloodstream, increasing the chances of fatality <a class="ref-link" href="#">[16]</a>.
				</p>
			<div class="spacer-small"></div>
			<p>
	Current diagnostics are slow, relatively inaccurate, or inaccessible. These issues can lead to misdiagnosis, discomfort or even an increased risk of death. Test inaccuracy often leads to misdiagnosis, which can have disastrous consequences. For instance, the symptoms of vulvovaginal candidiasis can overlap with the symptoms of bacterial vaginosis, necessitating the use of vaginal pH as a metric.
However, vaginal pH can be inadvertently influenced by periods, pregnancy, menopause, and intercourse. In these scenarios, patients may unnecessarily take antibiotics, both prolonging suffering and propagating antimicrobial resistance. 

Speed is also essential, especially in the context of treating invasive yeast infections. Although quickly becoming outdated, blood culture is one of the easiest ways to detect invasive yeast infections. Although simple, culture based-diagnostic can take several days to complete, 
time some patients may not have to give; a 24-hour delay in administering treatment for invasive candidiasis can increase mortality rates by 20% <a class="ref-link" href="#">[8]</a>.

If a test is inaccessible to users, however, speed and accuracy are inconsequential. Should a diagnostic test rely on resources not available to all or require expensive overhead and maintenance, 
as is often the case in rural and underdeveloped areas, afflicted may never receive a diagnosis and subsequent treatment; in the case of invasive candidiasis, 
inaccessibility is synonymous with death <a class="ref-link" href="#">[5]</a>. One treatment used to detect invasive yeast infection is the T2Dx system which uses magnetic resonance. 
Though accurate, the instrument costs $150,000, with each test costing up to $250 <a class="ref-link" href="#">[1]</a>. For the clinics of rural and underdeveloped communities lacking the capital to fund such a purchase, the “golden standard” for detecting C. albicans may as well not exist.
            </p>
			<div class="spacer-small"></div>
			<div class="table-responsive thumbnail">
			<table class="table table-bordered">
				<thead>
					<tr>
						<th>Methods of Diagnosis</th>
						<th>Time</th>
						<th>Cost</th>
						<th>Accuracy</th>
						<th>Expertise</th>
						<th>Capital investment</th>
						<th>Type of infection</th>
					</tr>
				</thead>
				<tbody>
					<tr>
						<td>Blood Culturing</td>
						<td class="danger">1-5 days <a class="ref-link" href="#">[3]</a></td>
						<td class="success">Low (cost of plate)</td>
						<td class="danger">50% <a class="ref-link" href="#">[7]</a></td>
						<td class="warning">Medium (Lab technicians can do)</td>
						<td class="warning">Medium (common equipment)</td>
						<td>Invasive</td>
					</tr>
					<tr>
						<td>Monistat</td>
						<td class="success">A few minutes</td>
						<td class="warning">Medium ($15 for 2) <a class="ref-link" href="#">[13]</a></td>
						<td class="danger">High, but can yield false positives</td>
						<td class="success">Low (self-diiagnosis)</td>
						<td class="success">none</td>
						<td>Vulvovaginal</td>
					</tr>
					<tr>
						<td>PCR</td>
						<td class="danger">1-5 days</td>
						<td class="success">Low (about $1 per reaction) <a class="ref-link" href="#">[9]</a></td>
						<td class="success">High (83.3% sensitivity) <a class="ref-link" href="#">[4]</a></td>
						<td class="warning">Medium (lab technicians)</td>
						<td class="danger">High (Requires equipment)</td>
						<td>Vulvovaginal</td>
					</tr>
					<tr>
						<td>CAGTA</td>
						<td class="warning">3 hours <a class="ref-link" href="#">[10]</a></td>
						<td class="warning">Medium ($13 per determination) <a class="ref-link" href="#">[10]</a></td>
						<td class="success">High (84-96% sensitivity) [10]</td>
						<td class="warning">Medium (Lab Technicians)</td>
						<td class="danger">High (Requires equipment)</td>
						<td>Invasive</td>
					</tr>
					<tr>
						<td>T2Dx</td>
						<td class="warning">4 hours <a class="ref-link" href="#">[11]</a></td>
						<td class="danger">High $250 per test</td>
						<td class="success">High (91% sensitivity) <a class="ref-link" href="#">[12]</a></td>
						<td class="warning">Medium (Lab Technicians)</td>
						<td class="danger">High (Requires Equipment)</td>
						<td>Invasive</td>
					</tr>
					<tr>
						<td>Microscopic examination</td>
						<td class="success">A few minutes <a class="ref-link" href="#">[14]</a></td>
						<td class="success">Low (cost of plate)</td>
						<td class="success">High (75-80%) <a class="ref-link" href="#">[14]</a></td>
						<td class="danger">High (Trained Specialist) <a class="ref-link" href="#">[14]</a></td>
						<td class="warning">Medium (common equipment)</td>
						<td>Vulvovaginal</td>
					</tr>
					<tr>
						<td>Purdue iGEM diagnostic test</td>
						<td class="success">Goal is for a few minutes</td>
						<td class="success">Goal is to be low</td>
						<td class="success">Goal is for high accuracy with high specificity</td>
						<td class="success">Low - goal is for anyone to use</td>
						<td class="success">Low - goal is to not require equipment to use</td>
						<td>Both</td>
					</tr>
				</tbody>
			</table>
			<div class="caption"><p>this is a table</p></div>
			</div>
			<div class="spacer-small"></div>
			<div class="thumbnail">
				<img src="../photos/RappamycinAssey.png"/>
				<div class="caption"><p>This is an image</p></div>
			</div>
			<div class="spacer-small"></div>
			<h1> What are we doing to solve this issue?</h1>
			<p>To meet the needs of those infected by and diagnosing C. albicans, we’ve identified three primary criteria as guidelines in the design of a superior diagnostic test: accuracy, accessibility, and speed. Design began by translating these criteria into base level assumptions. To improve accuracy, we would have to detect a biomarker as unique to C. albicans as possible. To make the test accessible, it would have to be relatively inexpensive, simple to use, and not require the use of any external machinery or resources. To make the test fast, we would have to avoid a relatively slow cell-based system and make use of cell-less alternatives. The culmination of these assumptions in the context of the problem background led to our current design: a 2-step paper-based test featuring a cell-less reaction and a decisive colorimetric output. The test will detect farnesol, indicative of systemic infection, and tyrosol, indicative of vulvovaginal infections; both molecules are relatively unique to C. albicans. The binary output mechanism of the test revolves around the state of horseradish peroxidase (HRP), an enzyme capable of oxidizing colorless substrates like tetramethylbenzidine (TMB) to form colored products. Split and non-split versions of HRP constitute the non-functional and functional versions of the enzyme, respectively. A locking mechanism will consist of split proteins that recombine in the presence of a target biomarker: farnesol with pqsR, tyrosol with tyrosinase. The locking mechanism and output mechanism are attached to each other such that HRP is functional only when a biomarker and the respective split halves “lock” around it. To receive a diagnosis, patients must first retrieve a sample of infected material and then introduce the sample to our test. If the paper turns blue, they have a yeast infection.
			
			Increasing accessibility provides a solution to those who do not have the training to use laboratory equipment, cannot afford the medical appointments necessary, or do not have time to schedule testing with a doctor. Improved test accuracy and test speed decrease the rate of misdiagnosis and the time required for patients to receive treatment, thus decreasing mortality rate, patient suffering, and inappropriately prescribed antibiotics and antifungals. The decrease in the use of these drugs will also decrease the prevalence of multidrug-resistant pathogens, allowing the treatments to remain as viable options to patients in need.
			</p>
			<h1>References</h1>
			<ol class="references">
				<li>Anonymous, “With MRI Platform, Mass. Firm Aims To Upend Sepsis Diagnosis,” MDDI Online, 20-Feb-2015. [Online]. Available:https://www.mddionline.com/mri-platform-mass-firm-aims-upend-sepsis-diagnosis. [Accessed: 31-May-201</li>
				<li>D. Friedman, E. Temkin, and Y. Carmeli, “The negative impact of antibiotic resistance,” Clinical Microbiology and Infection, vol. 22, no. 5, pp. 416–422, May 2016</li>
				<li>H. C. Chang, S. N. Leaw, A. H. Huang, T. L. Wu, and T. C. Chang, “Rapid Identification of Yeasts in Positive Blood Cultures by a Multiplex PCR Method,” J Clin Microbiol, vol. 39, no. 10, pp. 3466–3471, Oct. 2001.</li>
				<li>C. Valero, L. de la Cruz-Villar, Ó. Zaragoza, and M. J. Buitrago, “New Panfungal Real-Time PCR Assay for Diagnosis of Invasive Fungal Infections,” J. Clin. Microbiol., vol. 54, no. 12, pp. 2910–2918, Dec. 2016. </li>
				<li>“Healthcare Disparities and Barriers - Factsheets - Rural Health - Stanford University School of Medicine.” [Online]. Available: http://ruralhealth.stanford.edu/health-pros/factsheets/disparities-barriers.html. [Accessed: 31-May-2018].</li>
				<li>“Yeast infection (vaginal) - Symptoms and causes,” Mayo Clinic. [Online]. Available: http://www.mayoclinic.org/diseases-conditions/yeast-infection/symptoms-causes/syc-20378999. [Accessed: 31-May-2018].</li>
				<li>“Blood test cuts time to diagnosis for common, deadly yeast infection, national trial shows,” ScienceDaily. [Online]. Available: https://www.sciencedaily.com/releases/2018/02/180209174532.htm. [Accessed: 31-May-2018]</li>
				<li>M. A. Pfaller and D. J. Diekema, “Epidemiology of Invasive Mycoses in North America,” Critical Reviews in Microbiology, vol. 36, no. 1, pp. 1–53, Feb. 2010.</li>
				<li>“GenScript - Make Research Easy - The leader in molecular cloning and gene synthesis, peptide synthesis,protein and antibody engineering.” [Online]. Available: https://www.genscript.com/search?q=real-time+PCR&g=product&t=Molecular+Biology+Products. [Accessed: 31-May-2018].</li>
				<li>M. C. Martínez-Jiménez et al., “Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia,” Med Mycol, vol. 52, no. 3, pp. 270–275, Apr. 2014.</li>
				<li>P. Muñoz et al., “T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study,” J Antimicrob Chemother, vol. 73, no. suppl_4, pp. iv6–iv12, Mar. 2018.</li>
				<li>“T2Candida Panel,” T2 Biosystems. [Online]. Available: https://www.t2biosystems.com/t2direct-diagnostics/t2candida-panel/. [Accessed: 31-May-2018].</li>
				<li>“Amazon.com: Monistat Vaginal Health Test, 2 Count: Prime Pantry.” [Online]. Available: https://www.amazon.com/Monistat-Vaginal-Health-Test-Count/dp/B01MSCSC7D/ref=sr_1_5_a_it?ie=UTF8&qid=1527790903&sr=8-5&keywords=monistat+yeast+infection+test. [Accessed: 31-May-2018].</li>
				<li>L. Yang, “Interview with Dr.Lisa Yang,” 24-May-2018.[Phone Call]</li>
				<li>“Vaginal Candidiasis | Fungal Diseases | CDC,” 07-Aug-2017. [Online]. Available: https://www.cdc.gov/fungal/diseases/candidiasis/genital/index.html. [Accessed: 31-May-2018].</li>
				<li>“Symptoms | Invasive Candidiasis | Candidiasis | Types of Diseases | Fungal Diseases | CDC,” 20-Mar-2017. [Online]. Available: https://www.cdc.gov/fungal/diseases/candidiasis/invasive/symptoms.html. [Accessed: 31-May-2018].</li>
			</ol>
			<div class="spacer-small"></div>
		</div>
	</div>	
</body>
</html>


<html>
<head>
  <title>Bootstrap Example</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <!-- <link rel="stylesheet" href="bootstrap/bootstrap.min.css">
  <script src="bootstrap/jquery.min.js"></script>
  <script src="bootstrap/bootstrap.min.js"></script> -->
  <link rel="stylesheet" type="text/css" href="../css/NavBarBoot.css">
</head>
<body>
	<div style="display:block;">
	<div class="footer">
		<div class="igem_2018_team_content" style="background-color:inherit;">
			<div class="igem_2018_team_column_wrapper">
				<div class="column third_size footer-thanks">
					<h1>Special Thanks</h1>
					<a class="footer-text-link" href="http://2018.igem.org/Team:Purdue/Acknowledgement">
					<p>to all those that made this possible</p></a>
					<img class="social social-purdue" src="../photos/Purdue.png" style="height:5em;width:auto;"/>
				</div>
				<div class="column third_size">
					<h1>Follow Us On</h1>
					<div class="column third_size">
						<a href="https://twitter.com/purdueigem">
						<img class="social" src="../photos/twitter.png"/></a>
					</div>
					<div class="column third_size">
						<a href="https://www.instagram.com/purdueigem/">
						<img class="social" src="../photos/instagram.png"/></a>
					</div>
					<div class="column third_size">
						<a href="https://www.facebook.com/PurdueiGEM/">
						<img class="social" src="../photos/facebook.png"/></a>
					</div>
				</div>
				<div class="column third_size">
					<h1>Contact Us</h1>
					<p>[Team Email]</p>
					<p>[Team Address]</p>
				</div>
			</div>
		</div>
	</div>
	</div>
</body>
</html>